Funding
Cancer
CANCER
This study was supported by grants (U10CA180868, UG1CA189867, and U10CA180822) from the National Cancer Institute and by funding and the provision of olaparib and placebo by AstraZeneca as part of an alliance between AstraZeneca and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.